Peptides from Bitter Melon as a natural aid for diabetes and hypertension

Herbs and Phytochemicals: Bitter melon, often praised for its health benefits, may have more to offer than we once thought. A recent study has identified peptides in bitter melon seeds that hold promise in combating both type 2 diabetes (T2D) and hypertension. Researchers from institutions in Taiwan and Indonesia, including the National Pingtung University of Science and Technology and Universitas Brawijaya, explored how certain peptides in bitter melon seeds inhibit enzymes associated with these conditions. This Herbs and Phytochemicals news report delves into the findings, highlighting the peptides’ potential as a natural alternative to synthetic medications.


Peptides from Bitter Melon as a natural aid for diabetes and hypertension

The Search for Natural Remedies
With the rising prevalence of type 2 diabetes and hypertension, there's an urgent need for effective, safe treatments. Both conditions are often managed with synthetic drugs, but these medications can come with a range of side effects. Many patients and researchers are now looking toward natural remedies that may offer fewer complications. Bitter melon, a fruit long used in traditional Asian medicine, is known for its blood sugar-lowering properties. This study sought to understand whether peptides derived from its seeds could offer targeted benefits against diabetes and hypertension.
 
Key Findings on Bitter Melon Peptides
Researchers conducted extensive tests on peptides isolated from bitter melon seeds, particularly focusing on how these peptides interact with two critical enzymes: dipeptidyl peptidase-IV (DPP4) and angiotensin-converting enzyme (ACE). The inhibition of these enzymes plays a significant role in managing diabetes and hypertension, respectively.
 
The study identified two main peptides, labeled as MW4 and VF7, that demonstrated potent inhibitory effects on DPP4 and ACE. DPP4 inhibitors help regulate blood sugar levels, while ACE inhibitors are commonly used to manage blood pressure. By inhibiting these enzymes, the peptides could potentially control glucose levels in diabetes and reduce hypertension. Notably, MW4 was found to be effective against both enzymes, making it a particularly promising candidate for patients dealing with both conditions.
 
How the Peptides Work
The MW4 peptide, identified as MPHW, showed an impressive DPP4 inhibitory effect, with an IC50 value (a measure of its effectiveness) of 128.0 ± 1.3 µM. This level of activity suggests that MW4 could compete with synthetic DPP4 inhibitors currently used in diabetes treatment. VF7, on the other hand, exhibited a slightly less potent DPP4 inhibitory effect but still showed promise. The ACE inhibitory action of MW4 further underscores its potential as a multifunctional treatment for people with diabetes and hypertension.
 
Molecular docking simulations revealed that MW4 interacts effectively with the active sites of DPP4 and ACE, preventing these enzymes from breaking down crucial peptides and hormones that regulate blood sugar and blood pressure. This competitive inhibition mechanism implies that these peptides could work similarly to synthetic drugs, but with a potentially lower risk of side effects.
 
Stability of Peptides in Digestion
For any natural treatment to be effective, it must withstand the human digestive system without losing its potency. This study simulated the gastrointestinal digestion process to test whether MW4 and VF7 peptides could survive. The results were encouraging: both peptides remained stable through simulated digestion, indicating that they could retain their beneficial effects when taken orally. This stability also suggests that the peptides could be developed into a dietary supplement or functional food ingredient for easier integration into daily routines.
 
Broader Implications of the Study
The dual-function nature of these peptides could mark a significant advancement in the treatment of metabolic diseases. As noted, managing both diabetes and hypertension can be challenging due to the complexities of each condition and their common coexistence. Patients often require multiple medications, each with potential side effects, leading to treatment fatigue and compliance issues. Natural treatments like bitter melon peptides could offer a holistic approach, addressing both conditions with a single supplement. Additionally, the study supports a trend toward food-derived therapeutics, providing a gentler, more natural treatment alternative.
 
Next Steps and Future Research
While the results are promising, the researchers emphasize that more studies are necessary. Future research should investigate the in vivo (in living organisms) effects of these peptides to confirm their efficacy and safety. Clinical trials will also be essential to establish proper dosages and delivery methods, as well as to verify any long-term benefits or potential side effects. Nevertheless, this study has paved the way for further exploration of bitter melon and similar natural products in treating chronic health conditions.
 
Conclusion
The findings from this study suggest that peptides derived from bitter melon seeds could be a natural alternative for managing type 2 diabetes and hypertension. These peptides, particularly MW4, showed strong inhibitory effects on both DPP4 and ACE enzymes, suggesting that they may help control blood sugar and blood pressure levels. The stability of these peptides during digestion also highlights their potential as a practical and effective supplement.
 
As we continue to look for natural remedies to complement or replace synthetic drugs, bitter melon peptides could play an important role in the future of metabolic disease management. While more research is needed to confirm these findings in human trials, this study offers hope for a new approach to treating two of the most common and challenging health conditions facing the world today.
 
The study findings were published in the peer-reviewed journal: Biomedicines.
https://www.mdpi.com/2227-9059/12/11/2452
 
For the latest on Herbs and Phytochemicals, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/herbs-phytochemicals-unlocking-the-potential-of-traditional-chinese-medicine-daurisoline-enhances-diabetes-treatment-by-inhibiting-microbial-dpp4
 
https://www.thailandmedical.news/news/herbs-and-phytochemicals-tiliroside-from-the-herb-potentilla-chinensis-is-a-natural-nrf2-activator-that-helps-with-diabetic-nephropathy
 
https://www.thailandmedical.news/news/a-phytochemical-in-cruciferous-vegetables-may-slow-skin-aging-and-inflammation